CONSUMER HEALTHCARE HOLDINGS LIMITED

Company number 11986432

Date	Type	Description	View / Download
04 Oct 2024	AP01	Appointment of Khalid El Ansari as a director on 10 September 2024	(2 pages)
18 Sep 2024	TM01	Termination of appointment of Mariano Jesus Godino Escolar as a director on 9 September 2024	(1 page)
20 Aug 2024	AA	Audit exemption subsidiary accounts made up to 31 December 2023	(27 pages)
20 Aug 2024	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/23	(224 pages)
20 Aug 2024	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/23	(1 page)
20 Aug 2024	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/23	(3 pages)
13 May 2024	CS01	Confirmation statement made on 8 May 2024 with updates	(4 pages)
02 Oct 2023	AA	Full accounts made up to 31 December 2022	(32 pages)
16 Jun 2023	PSC05	Change of details for Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited as a person with significant control on 16 June 2023	(2 pages)
02 Jun 2023	CH02	Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022	(1 page)
23 May 2023	CS01	Confirmation statement made on 8 May 2023 with no updates	(3 pages)
23 May 2023	AD02	Register inspection address has been changed from 980 Great West Road Brentford Middlesex TW8 9GS United Kingdom to Equiniti Highdown House Yeoman Way Worthing West Sussex BN99 3HH	(1 page)
17 May 2023	CH02	Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023	(1 page)
03 Oct 2022	AA	Full accounts made up to 31 December 2021	(32 pages)
15 Aug 2022	CH01	Director's details changed for Mr Scott Christopher Bourgeois on 30 June 2022	(2 pages)
18 Jul 2022	AD01	Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022	(1 page)
13 Jun 2022	AP01	Appointment of Mr Scott Christopher Bourgeois as a director on 6 June 2022	(2 pages)
07 Jun 2022	TM01	Termination of appointment of Nicholas Ian Cooper as a director on 6 June 2022	(1 page)
23 May 2022	CS01	Confirmation statement made on 8 May 2022 with no updates	(3 pages)
06 Apr 2022	TM01	Termination of appointment of Glaxo Group Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022	(2 pages)
19 Nov 2021	SH19	Statement of capital on 19 November 2021 USD 6,649,579 GBP 248,031.34	(3 pages)
19 Nov 2021	SH20	Statement by Directors	(2 pages)
19 Nov 2021	CAP-SS	Solvency Statement dated 18/11/21	(2 pages)
19 Nov 2021	RESOLUTIONS	Resolutions RES13 ‐ Reduction of share premuim account 18/11/2021 RES06 ‐ Resolution of reduction in issued share capital	(3 pages)

• 1
• 2
• 3

Next